Ceftru-CV Dry Syrup
Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg Dry Syrup
| Composition | Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg per 5 ml (Dry Syrup) |
|---|---|
| Dosage Form | Dry Syrup |
| Pack Type | Bottle with Water |
| Pack Size | 30 ml Bottle |
| MRP | ₹ 141.9 |
| Therapy | Paediatric + Antibiotic — Third-Gen Cephalosporin + Beta-Lactamase Inhibitor |
| Storage | Dry powder below 30 °C. After reconstitution, refrigerate and use within 10 days. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Ceftru-CV Dry Syrup
Ceftru-CV Dry Syrup combines Cefpodoxime 50 mg with Clavulanic Acid 31.25 mg per 5 ml. The clavulanate addition extends cefpodoxime’s already broad spectrum to fully cover beta-lactamase-producing organisms — particularly important in recurrent paediatric otitis media and sinusitis.
The combination is preferred in regions with high beta-lactamase prevalence or in children with recent antibiotic exposure.
Ceftru-CV Dry Syrup is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Indications
- Recurrent paediatric otitis media
- Acute paediatric sinusitis
- Lower respiratory tract infections with beta-lactamase suspicion
- Paediatric pneumonia with prior antibiotic exposure
Mechanism of Action
Cefpodoxime Proxetil is an oral third-generation cephalosporin prodrug that is hydrolysed in intestinal mucosa to active cefpodoxime. It binds penicillin-binding proteins, inhibiting peptidoglycan cross-linking. Broad spectrum covering gram-negative (H. influenzae, M. catarrhalis, E. coli, Klebsiella) and selected gram-positive (streptococci, MSSA) organisms — including many beta-lactamase-producing strains. Clavulanate inhibits bacterial beta-lactamases.
Dosage & Administration
Children: 10 mg/kg/day of cefpodoxime in two divided doses for 5–10 days. Reconstitute with supplied water; refrigerate after reconstitution.
Side Effects
Diarrhoea, nausea, vomiting, mild rash, headache. Rare: pseudomembranous colitis, anaphylaxis, severe skin reactions. Cross-reactivity with penicillin allergy (~5–10%). Increased GI upset due to clavulanate.
Contraindications & Precautions
Hypersensitivity to cephalosporins. Severe penicillin allergy. Caution in renal impairment (dose adjustment). Caution in GI disease. History of cholestatic jaundice with clavulanate.
Storage
Dry powder below 30 °C. After reconstitution, refrigerate and use within 10 days.
Ceftru-CV Dry Syrup is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Ceftru-CV Dry Syrup used for?
Ceftru-CV Dry Syrup contains Cefpodoxime + Clavulanic Acid paediatric dry syrup and is used for bacterial infections — UTI, ENT, respiratory tract, skin/soft-tissue infections in the appropriate age group.
How long is the course?
Typical course is 5–10 days; longer in complicated infections. Always complete the prescribed course.
Is Ceftru-CV Dry Syrup available for PCD pharma franchise?
Yes, Trumac Healthcare offers Ceftru-CV Dry Syrup on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Ceftru-CV Dry Syrup be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Ceftru-CV Dry Syrup WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Ceftru-CV 100 Dry Syrup — Cefpodoxime 100 mg + Clavulanic Acid 62.5 mg per 5 ml (Dry Syrup)
- Ceftru-CV 100 Tablet — Cefpodoxime 100 mg + Clavulanic Acid 62.5 mg
- Ceftru-50 Dry Syrup — Cefpodoxime Proxetil 50 mg / 5 ml (Dry Syrup with Water)